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3.1 Introduction 
The biocompatibility of a material is crucial in branding it as a biomaterial. Building 
on the previous biocompatibility chapter, this chapter mainly focuses on the assessment 
of biocompatibility. The main aims of biocompatibility assessment are: 1) raw material 
characterisation; 2) in vitro; and 3) in vivo assessment of materials. Figure 3.1 shows 
a schematic representation of the components of biocompatibility assessment. This 
chapter will deal with each of these characterisations and assessment methods one 
by one in the following sections. 
Materials
characterisation
In vitro assessment In vivo assessment
Biocompatability
Figure 3.1 Major aspects of biocompatibility assessment
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3.2 Raw Materials Characterisation
3.2.1 Introduction
Biomaterials have distinct bulk and surface characteristics. Knowledge of these 
characteristics is important in selecting the appropriate material for biomedical 
applications. An understanding of the methods used to characterise biomaterials is 
therefore essential for anyone working within the field of biomaterials engineering. 
Biomaterials characterisation deals mainly with the chemical, physical and mechanical 
characterisation of bulk and surface properties. This section hopes to provide a clear 
and concise guide to help biomaterials researchers select the appropriate tool from 
the vast array of specialised techniques available to them. Please see Table 3.1 for a 
summary of the discussed methods.
3.2.2 What are Bulk and Surface Properties?
The properties of a material are not homogeneous but differ depending on a number 
of factors. Bulk properties are defined as those that remain constant regardless of 
the amount of material. For the purposes of biomaterials, the bulk can be seen 
as everything that is not part of the surface. On the other hand, the surface of 
a material is the termination of the three-dimensional (3D) bulk [1]. This area of the 
material represents an increase in energy and here dangling or unsaturated bonds can 
be found. These dangling bonds form new bonds when within a reactive environment, 
serving to lower the surface energy. It is therefore often the case that the properties 
of the surface differ significantly from that of the bulk. A practical example of these 
principles at work is the composition of a titanium orthopaedic implant. Within a 
fraction of second of exposure to an oxygen-rich environment, a 2−10 nm surface 
layer of titanium dioxide (TiO2) builds up (Figure 3.2). Various other environmental 
contaminants are also adsorbed onto the surface, including hydrocarbons. Thus, the 
sum of the bulk and surface properties determine, to a large extent, the successful 
application of any particular biomaterial. Special emphasis is often placed on surface 
properties as this contributes directly to the in vitro response to the biomaterial 
including protein adsorption, cell adhesion, cell growth and blood compatibility. For 
this reason, specialised techniques are required to adequately characterise the surface 
of a biomaterial [2]. 
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Figure 3.2 Dynamic changes at the interface of a titanium implant when exposed 
to air
Contamination
2-10 nm TiO2
Titanium
Time (s)
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3.2.3 Bulk Characterisation of Biomaterials
3.2.3.1 Transmission Electron Microscopy
•	 Application 
 Transmission electron microscopy (TEM) is used to study the internal structure 
of biomaterials at a high resolution and is able to provide morphological, 
crystallographic and compositional information of inorganic materials. TEM 
allows imaging of materials to resolutions in the order of a fraction of a nanometre 
while simultaneously obtaining diffraction information. Use of high energy 
electrons (>100 kV) results in the excitation of atoms in the specimen allowing 
further spectroscopic techniques, including energy-dispersive X-ray spectroscopy 
(EDS), to provide chemical characterisation [3]. 
•	 Theory 
 The transmission electron microscope is the original form of the electron 
microscope. In its current form it is one of the most powerful techniques available 
to the biomaterials researcher. During TEM, a beam of electrons is produced by 
an electron gun and then focused by a series of electrostatic lenses. This focused 
beam illuminates a thin specimen mounted on a grid. As the electron beam passes 
through the specimen, some electrons are transmitted whilst others are scattered or 
refracted. The typical accelerating voltage (the voltage used to drive the electron 
beam) is in the order of 100 kV to 1 MV, which allows penetration of samples 
<50 nm thick. Finally, the transmitted electrons are displayed using a fluorescent 
screen. 
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•	 Advantages
o Very high resolution (<10 Å). 
o Provides information on the chemical structure.
•	 Disadvantages
o Sample preparation is time-consuming. 
o Equipment is large and expensive. 
o TEM is limited to samples that can tolerate a vacuum and are electron 
transparent.
•	 Example
 Analysis of the particle size of carbonate anion intercalated magnesium-aluminium-
layered double hydroxide and other inorganic materials such as hydroxyapatite 
(HA), quantum dots (QD) and ferrous nanoparticles. 
3.2.3.2 X-ray Diffraction Spectroscopy
•	 Application 
 X-ray diffraction (XRD) spectroscopy is a nondestructive analytical technique 
which characterises the crystalline phases and orientation of raw materials based 
on the arrangement of the atoms in their crystal structures. The crystal structure 
of a material consists of different layers or planes with a similar function to a 
semitransparent mirror. XRD uses a collection of single-phase diffraction patterns 
whose repeat distance is similar to the distances between the phases of the crystal 
structure. As the wavelength of X-rays is applied to the material it reflects at about 
the same angle of reflection as that of the phases of the crystal structure, leading 
to the phenomenon of diffraction. XRD spectroscopy is a very useful method to 
determine the structural properties (e.g., strain, grain size, phase composition and 
thermal expansion) of a raw material. It can also be used to measure the thickness 
of thin films and multilayers within a structure. Furthermore, it can be used to 
measure the size, shape and internal stress of small crystalline regions within the 
material [4]. 
•	 Theory 
 The phenomenon of diffraction is based on Bragg’s law, which provides the angles 
for coherent and incoherent scattering from the crystal structure of the material. 
According to Bragg’s law, diffraction takes place when 2dsinθ = nλ, where n is 
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an integer, λ is the wavelength of the incident wave, d is the spacing between the 
planes in the atomic lattice, and θ is the angle between the incident ray and the 
scattering planes. 
When X-ray beams are directed at the material they become scattered and create 
peaks of scattered intensity where the following two conditions apply: 
o The angle of incidence is equal to the angle of scattering. 
o The path length difference is equal to an integer number of wavelengths. The 
pattern of XRD is unique to each substance, which allows the identification 
of phases within a given sample.
•	 Advantages 
o Nondestructive method.
o Powerful and rapid technique. 
o Minimal sample preparation required. 
o Data interpretation is relatively simple. 
o Can be used to identify unknown materials by comparing their crystal 
structure to the library of the materials.
•	 Disadvantages	
o Specimen displacement. 
o Instrument misalignment.
o Peak overlay may occur. 
o Has size limitations (more accurate on larger crystalline structures). 
o For mixed materials, the detection limit is ~2% of the sample.
3.2.3.3 Fourier-Transform Infrared Spectroscopy
•	 Application	
 Fourier-transform infrared spectroscopy (FTIR) is the most common form of 
infrared spectroscopy. It is a form of absorption spectroscopy which results in a 
characteristic ‘signature’ absorption spectrum. This absorption spectrum allows 
the quantitative identification of many inorganic compounds, determination 
of the molecular composition of surfaces and determination of molecular 
orientation [5].
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•	 Theory 
 Infrared spectroscopy works via measuring the absorption of electromagnetic 
radiation (EM) with frequencies between 12,800 cm-1 and 10 cm-1. When exposed 
to infrared radiation, vibrational excitation is induced in covalently bonded atoms 
of the sample causing a change in dipole moment. These absorptions result in 
absorption peaks in the infrared (IR) spectrum. Absorption peaks are presented 
as wavenumbers (ν) with the unit cm-1. This represents the number of waves 
per centimetre and is used as it is proportional to energy. The IR spectrum is 
subdivided into near-IR (4,000−14,000 cm-1), mid-IR (400−4,000 cm-1) and far IR 
(25−400 cm-1). Mid-IR is commonly used to characterise materials as this region 
corresponds to the majority of primary absorption frequencies. For inorganic 
materials, far-IR is sometimes used as inorganic compounds such as silicides, 
borides and nitrides do not absorb radiation in the 4,000−400 cm-1 range. 
FTIR differs from dispersive IR spectrometers through the use of a Fourier-Transform 
applied to an interferogram. The main benefit derived is the ability to measure multiple 
frequencies of IR radiation simultaneously compared with the more time-consuming 
method of measuring one frequency at a time. 
•	 Advantages 
o Very fast characterisation of biomaterials as all frequencies are measured 
simultaneously.
o Nondestructive method.
o Good signal-to-noise ratio. 
o Ability to characterise materials in solid, liquid and gaseous phases.
o Accurate wavelength calibration allowing spectral subtraction to remove, for 
example, the spectrum of a solvent.
•	 Disadvantages	
o Cannot detect atoms or monoatomic ions as they don’t contain any bonds. 
o Aqueous solutions are difficult to analyse as water absorbs IR.
3.2.3.4 Dynamic Light Scattering 
•	 Application 
 Dynamic light scattering (DLS) is a method of measuring the size, size distribution 
and shape of nanoparticles in solution. DLS is a versatile tool that can be used in 
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most situations where inorganic particles are in solution, one example being the 
measurement of QD size [6]. 
•	 Theory 
 DLS works through the measurement of the intensity of light scattered by the 
molecules in the sample solution as a function of time. Due to Brownian motion 
in the solution, interference occurs in the scattered light. This causes a change in 
light intensity which is measured in relation to time. The faster the rate of diffusion 
or Brownian motion within the solution, the faster the intensity fluctuations will 
occur. Considering all other variables are controlled, the speed of diffusion is a 
result of the size of the particles. This allows the size or hydrodynamic radius of 
the particle to be inferred based on the rate of diffusion. 
•	 Advantages 
o Fast characterisation of particle size in solution. 
o Nondestructive method. 
o Automated and not dependent on an operator. 
o Can be performed on a small sample.
•	 Disadvantages 
o Sample can be easily contaminated. 
o Sensitive to mechanical disturbances. 
o Limited to measuring particles in solution.
3.2.3.5 Mercury Intrusion Porosimetry
•	 Application 
 Porosity is an important property of many biomaterials and is defined as the ratio 
of void space to the total volume. Porous and connected networks are essential 
for cell proliferation, nutrition, cell migration, vascularisation and new tissue 
formation. Furthermore, a porous material allows better biointegration through 
an increased surface area and therefore larger biointerface. Mercury intrusion 
porosimetry (MIP) allows the biomaterials researcher to measure total pore 
diameter and mean pore size.
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•	 Theory	
 During MIP, the sample is placed in a mercury penetrometer and is subsequently 
infused with mercury using continuously increasing pressures. The method is based 
on the principle that the pressure required to fill the pores of a sample, with a 
nonwetting liquid, is inversely proportional to the diameter of the pores. Thus, 
higher pressures will be required to fill pores of smaller diameters due to higher 
surface tension forces. Although most nonwetting liquids can be used, mercury is 
especially suitable as it does not fill pores by capillary action. By monitoring the 
intrusion of mercury into the pores under highly controlled pressures, the pore 
size and volume distribution can be calculated. 
 Although MIP is useful for the generalised characterisation of porosity, it has 
drawbacks. Regarding the overall porosity, MIP does not take into account the 
existence of closed pores. Furthermore, it cannot differentiate between blind 
and through pores; this is important as through pores have been shown to 
positively impact the performance of biomaterials. In addition, the shape and 
morphology of pores cannot be measured. The results garnered are therefore 
more an approximation and rather crude. Practical aspects also hamper the 
overall usefulness of the technique as materials that cannot withstand the required 
pressures can be destroyed, nor can easily compressible materials be measured. 
•	 Advantages 
o Almost any material can be measured. 
o Can characterise a large range of mean pore sizes.
•	 Disadvantages	
o Pore morphology cannot be accurately measured. 
o Only measures mean pore size. 
o Some materials cannot withstand high pressure environments. 
o Does not measure closed pores. 
o Destructive due to the toxicity of mercury.
3.2.3.6 X-ray Computed Tomography 
•	 Application 
 X-ray computed tomography (CT) imaging can be used to obtain accurate 
3D morphological data on scaffolds. In particular, CT imaging overcomes the 
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disadvantages of MIP by providing detailed data on porosity, pore sizes, closed 
pores and pore interconnectedness. 
•	 Theory 
 CT imaging works by dividing the sample into a series of two-dimensional (2D) 
X-ray slices. Once the entire sample has been sliced, 3D modelling software builds 
an intricate 3D model of the sample from the individual 2D slices. 3D computation 
can then be performed on the model to calculate accurate data on the required 
properties. This technique is applicable to most bioceramics and bioglasses, but 
optimal results are difficult when dealing with metals due to heavily attenuated 
X-rays. 
•	 Advantages	
o Provides an intricate 3D model of exterior and interior surfaces. 
o Accurate porosity measurements. 
o Nondestructive technique.
•	 Disadvantages	
o Cannot be used on metallic materials.
3.2.4 Surface Characterisation of Biomaterials
3.2.4.1 X-ray Photoelectron Spectroscopy
•	 Application 
 X-ray photoelectron spectroscopy (XPS), also called electron spectroscopy, for 
chemical analysis is a surface characterisation method able to sample to a depth 
of 2−5 nm. XPS provides quantitative and qualitative information about the 
elements present at the surface and the bonds between them. XPS is unable to 
detect hydrogen and helium. XPS is useful for determining elemental composition, 
chemical state information and surface imaging. 
•	 Theory 
 XPS is based on the photoelectric effect, described by Albert Einstein in 1905. 
During XPS a sample is placed in an ultrahigh vacuum chamber and then 
bombarded with X-ray radiation. This causes a transfer of energy from the X-rays 
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and results in the emission of a photoelectron. The kinetic energy of the emitted 
electron is calculated using the binding energy of the electron and the energy of 
the incident X-ray. The kinetic energy is characteristic of a particular element and 
is then plotted on a graph of number of electrons detected (intensity – Y-axis) 
over binding energy (electron volts – X-axis). 
•	 Advantages	
o Can characterise all elements other than hydrogen and helium. 
o Can provide information on the chemical states of samples. 
o XPS can differentiate between the oxidation states of molecules. 
o Simple to interpret and widely used.
•	 Disadvantages	
o Poor absolute sensitivity with minimum levels of 0.1−0.5% required for 
detection.
3.2.4.2 Secondary Ion Mass Spectrometry
•	 Application	
 Secondary ion mass spectrometry (SIMS) is an important characterisation tool 
and compliments the use of XPS. SIMS produces a mass spectrum of atoms and 
molecules, and is able to sample to a depth of around 1 nm. SIMS is able to 
identify all elements, suggest the molecular structure and is particularly suitable 
for inorganic characterisation. It has also been used for submicron imaging and 
chemical mapping of both organic and inorganic materials. 
•	 Theory	
 Similarly to XPS, SIMS takes place within an ultrahigh vacuum chamber. SIMS 
analysis uses a focused and accelerated beam of ions (5−20 keV) to bombard the 
sample. This bombardment causes the sputtering of the surface particles into the 
vacuum. These ejected particles are secondary ions, radicals and neutral particles. 
The ejected secondary ions are then measured using mass spectrometry. The ratio 
of the mass-to-charge (m/z) of the ejected ions is measured and used to characterise 
the particles. This provides a spectrum of particle count over mass-to-charge (m/z) 
ratio. Typical measurements are made using a time-of-flight mass analyser. 
 Two types of SIMS analysis exist, known as dynamic SIMS and static SIMS. 
Static SIMS aims to minimise surface destruction through the use of an adjusted 
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ion dose, resulting in minimal ion sputtering. By limiting the incident ion dose, 
sputtering will be limited to the outermost monolayer, essentially leaving the 
surface unchanged. 
 Dynamic SIMS is a more complex technique which yields more information but 
is destructive in nature. During dynamic SIMS, relatively high ion doses are used 
to maximise secondary ion sputtering. Enough material is sputtered that the 
surface appreciably erodes over time and this provides a spectrum which will be 
representative of the average composition of the sampled volume. This therefore 
makes dynamic SIMS a useful technique for depth profiling of the surface by 
measuring the continuous peak intensity as a function of time. 
•	 Advantages	
o Very high surface specificity (higher than XPS). 
o Can detect hydrogen and helium. 
o Can generate a wealth of molecular and structural information. 
o Particularly suitable for inorganic applications. 
o Carbon buckyballs can be used as sputtering ions to provide a less destructive 
method of analysing sensitive biomaterial surfaces.
•	 Disadvantages	
o Quantification is difficult due to the poorly understood sputtering process. 
o Can be destructive; however, this is utilised by dynamic SIMS to allow depth 
profiling of biomaterials.
3.2.4.3 Optical Microscopy and Confocal Microscopy
•	 Application	
 Optical microscopy is the most commonly used method to examine the 
microstructure of a biomaterial. Techniques developed by metallurgists to 
investigate metal surfaces have also been applied to other biomaterials, including 
ceramics. On its most basic level, light microscopy provides a visual image of the 
surface of a material and will allow measurements of surface characteristics within 
the limits of the resolution afforded by the wavelength of visible light [7].
•	 Theory	
 There are many variations of optical microscopy with modifications and 
improvements in design for the purpose of increasing resolution, magnification 
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and contrast, and reduction in aberrations and artefacts. Here, the basic principles 
behind optical microscopes as well as a brief exploration of confocal microscopy 
will be introduced. 
 The main components of an optical microscope include the ocular lens, the 
objective lens, the specimen stage and the light source. Specimens are illuminated 
by the light source after which the light is focused and the image magnified by 
a series of lenses. The lens closest to the specimen is known as the objective lens 
and is responsible for the majority of the magnification. The image produced is 
further magnified and focused by the ocular or eyepiece lens. Optical microscopy 
is fundamentally limited to the resolution of the system. Resolution is defined as 
the minimum distance between two points at which they can still be told apart 
or resolved and is directly proportional to the wavelength of the radiation being 
used. In the case of optical microscopy, the best theoretical resolution possible 
is around 0.2 μm at a wavelength of 400 nm (violet light). Theoretically, the 
magnification of an image is limitless but in practice the inability to distinguish 
important features means that the effective magnification is limited to around 
1,000x. Of equal importance to magnification is the contrast and brightness of the 
image. Brightness decreases as magnification increases and needs to be carefully 
adjusted to allow the best possible visibility of the specimen. 
 Confocal microscopy is a form of optical microscopy which utilises spatial filtering, 
allowing an improved resolution as well as 3D imaging. In traditional optical 
microscopy, high resolution images are often obscured by a haze. A confocal 
microscope is able to isolate the plane of focus and remove the obscuring haze 
by utilising a pinhole or iris diaphragm. The main limitation of this system is 
that only the small area of focus is visible at one time. Confocal microscopes 
overcome this by using moving mirrors to scan an image which is then stitched 
together by a computer. Furthermore, by compiling the 2D images a 3D image 
can be constructed. 
•	 Advantages	
o Optical microscopes are cheaper in comparison to electron microscopes. 
o Direct viewing of samples with relatively simple preparation. 
o Samples can be viewed in colour. 
o Samples do not need to be viewed in a vacuum.
•	 Disadvantages	
o Low resolution compared with other imaging techniques.
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3.2.4.4 Scanning Electron Microscopy
•	 Application	
 Scanning electron microscopy (SEM) is able to provide very high resolution 
imaging of solid surfaces and is widely employed in the characterisation of 
biomaterials. SEM provides a large depth of field in comparison to its resolution 
and can analyse segments of 5 μm to 1 cm at a resolution of 50−100 nm. SEM is 
a versatile tool and can provide information on external morphology, chemical 
composition, crystalline structure and orientation of the surface of a material. 
It is useful to note that SEM is often combined with EDS to provide chemical 
characterisation of the sample surface. This will be explained in more detail below. 
•	 Theory	
 As with other forms of electron microscopy, an electron gun is used to produce 
a high energy beam of electrons which is subsequently focused by a series of EM 
lenses. The incident electrons produce a multitude of different signals as they 
collide and decelerate within the sample. These include secondary electrons, 
backscattered electrons, diffracted backscattered electrons, photons and others. 
SEM mostly utilises secondary electron detection to form an image of the sample 
and provides information regarding the morphology of the sample. Highlighting 
the versatility of SEM, the other resultant signals can also be measured to provide 
additional information. Commonly, backscattered electrons can be used to provide 
contact in multiphase samples. Also, as mentioned, EDS can characterise the 
chemical makeup of the material surface. This is possible due to the resultant 
X-rays, emitted as electrons within the sample atoms, returning to their lower 
energy state after inelastic collisions with the incident electrons. 
•	 Advantages	
o SEM is the most versatile tool available to the biomaterials scientist. 
o High resolution images, especially when compared with optical microscopy. 
o SEM creates beautifully immersive images. 
o SEM can provide a wealth of information when combined with other techniques.
•	 Disadvantages 
o Samples must be coated in a conductive material for the majority of 
conventional SEM. 
o SEM generally requires a high vacuum although other models are available 
that allow low vacuum environments. 
o SEM chambers can be small, limiting the size of the sample.
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3.2.4.5 Contact Angle Measurement
•	 Application	
 Contact angle measurement is used to characterise the hydrophilicity/
hydrophobicity of biomaterials. As mentioned earlier, these properties are essential 
to the future in vivo application of biomaterials and directly affects cell adhesion, 
migration and proliferation. There are a number of methods to measure contact 
angles, the most common of which will be discussed here [8]. 
•	 Theory 
 The contact angle is the angle formed at the intersect between the liquid-solid and 
liquid-gas interface. This angle is determined by the thermodynamic properties of 
the two materials and gives an indication regarding the wettability of a material. 
When a liquid spreads out over a surface, a small contact angle is measured 
and conversely, a large contact angle is measured when the liquid is stable and 
forms a bead. A contact angle of less than 90o indicates the material is wettable 
or hydrophilic in nature and the opposite is true for a contact angle over 90o. 
Therefore, an angle of 0o indicates very high hydrophilicity. Superhydrophobic 
surfaces, such as those seen on the lotus leaf, often have contact angles over 
150o. The thermodynamics governing contact angles is beyond the scope of this 
section. It is suffice to say that the most important point to understand in this 
case is the relationship between contact angle and wetting, and the applicability 
to bioengineering. Numerous methods exist to measure the contact angle, a few 
of which will be briefly discussed. Commonly used methods include the Wilhelmy 
method, the sessile drop method and the captive bubble method. 
 The Wilhelmy method is a technique that indirectly measures the contact 
angle. The sample is attached to a balance, lowered and brought into contact with 
a liquid. The change in force detected by the balance represents the buoyancy 
and the wetting force. With a known liquid surface tension and perimeter of the 
solid, the contact angle can be calculated. The method is a dynamic one and can 
measure contact angle hysteresis at different wetting speeds. It is also accurate as 
it is not dependent on visual measurements. 
 The sessile drop method is an optical method where a drop of liquid is placed on 
the solid surface and then measured by a contact angle goniometer. The method can 
be performed both statically and dynamically, where the dynamic version involves 
modifying the drop and measuring the advancing and receding angles. The sessile 
drop method is the most commonly used method in the field of bioengineering. 
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 The captive bubble method involves measuring the contact angle by submerging 
the solid in the liquid and ‘capturing’ a bubble of gas. The air bubble is then 
measured using a digital camera and the contact angle manually calculated from 
the image. 
3.2.5 Mechanical Characterisation of Biomaterials
3.2.5.1 Introduction
Detailed knowledge of the mechanical behaviour of biomaterials is essential for most 
applications. The importance is self-evident in many examples, such as dental implants, 
where the implant must be able to withstand the forces generated by mastication. Not 
only must a bioengineer be able to predict the failure of a prosthesis or implant, but 
also accurately predict the force relationships between the prosthesis and the body. 
For example, in the case where a prosthesis does not adequately transmit forces to 
the underlying tissue, such as bone, deficiencies in normal bone metabolism may lead 
to the prosthesis loosening and ultimately, failure. There have been many excellent 
books written on the topic of mechanical characterisation, so only commonly tested 
properties and corresponding techniques will be covered here [9, 10].
3.2.5.2 Tensile and Shear Properties
There are four forces that can be applied to a material; these are tensile, compressive, 
torsional and shear. In testing tensile strength, the properties measured are the 
engineering stress (σ) and engineering strain (ε). To measure these the sample is cut 
into a dog-bone shape and attached to a mechanical testing frame. This sample is 
then loaded over a longitudinal axis by moving one end of the frame. The force is 
applied, to a cross-sectional area of the sample, along the length of the sample and the 
stretched length of the sample is measured. By using these variables the engineering 
stress is calculated with the following formula: 
	 σ = FA0 (3.1)
Where: 
σ is the engineering stress.
F is the force applied. 
A0 is the original cross-sectional area of the sample. 
Copyright © 2014 Smithers Rapra.
60
Inorganic Biomaterials: Structure, Properties and Applications
The engineering strain is calculated as:
	 ε = li-l0FA0 (3.2)
Where: 
ε is the engineering strain. 
li is sample length. 
l0 is the original sample length. 
Using the above formulae, a stress-strain graph can be plotted. Where the curve follows 
a linear relationship, stress is directly proportional to strain, a relationship known 
as Hooke’s law. The slope of this curve gives the modulus of elasticity or stiffness of 
the material. Where Hooke’s law applies, the deformation is elastic, meaning it can 
return to its original shape upon release of the load. For a high stiffness, a large stress 
is required for deformation to occur. 
3.2.5.3 Time-dependant Properties
For biomaterials, short-term tests as mentioned previously do not paint the full 
picture. Longer term testing is necessary to predict the behaviour of biomaterials 
that may be expected to last for decades. One important time-dependent property 
to consider is creep. 
•	 Creep	
 Creep is the plastic deformation of a material under constant load over time. 
Creep is mostly applicable to polymers as it may occur at room temperature but 
can still occur in metals and ceramics. To test material creep, a constant tensile 
load is applied to a material whilst the temperature remains fixed. The strain 
is recorded as a function of time and plotted. Creep testing provides the steady 
creep rate of the material and the time to rupture for a given material at a given 
temperature.
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3.2.6 Cytotoxicity Testing of Inorganic Biomaterials
There are two types of cytotoxicity test; qualitative and quantitative. Qualitative 
cytotoxicity tests, such as direct contact and agar diffusion, are good methods for 
screening purposes. However, the quantitative assays such as 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) and tetrazolium salt (XTT) assays 
are preferred as they provide more data in a statistically comparable manner. In 
the cases of inorganic biomaterials such as bioglasses and bioceramics, MTT is the 
most commonly used assay. This is mainly because it can accurately quantify a low 
density cells and can be performed on either extracts or by direct contact. Another 
major advantage of this assay is that there is no need to subject the results to any 
interpretation by an analyst. Overall, it is a good assay for the fast screening of multiple 
samples with high accuracy. Despite various advantages leading to its frequent use, 
it should be noted that this particular assay does not differentiate between specific 
cellular death mechanisms, such as apoptosis or induced cell death, and in some 
cases fails to completely assess cellular damage as it only takes into account cellular 
death at its last stages. 
In addition to the above assays, other in vitro tests such as alamar blue and 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium can also be used to provide cell counts, based on colorimetric analysis, 
in order to measure the level of toxicity of inorganic biomaterials. These assays can 
be used on their own or in conjunction with other in vitro assays for the purposes of 
evaluation of the cytotoxicity of biomaterials (see Table 3.2 and Table 3.3). 
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3.2.6.1 Genotoxicity, Mutagenicity and Carcinogenicity Testing of 
Inorganic Biomaterials
The Ames assay is a bacterial reversed mutation assay used worldwide as an initial 
evaluation of the mutagenic potential of new medical devices/implants, chemicals and 
drugs. Ames is a fast, simple, sensitive and economically justified assay which can be 
used for all inorganic biomaterials. Ames of inorganic biomaterials such as bioglasses 
and bioceramics are routinely carried out on tester Salmonella typhimurium strains 
TA98, TA100, TA1535 and TA1537. It has been noticed from previous studies that 
some materials can be mutagenic to one tester strain while completely nontoxic to 
another. Therefore, it is best to use at least four strains to ensure the validity of the 
results [13].
The single cell gel electrophoresis assay, also known as the ‘Comet assay’, is another 
in vitro technique to evaluate DNA damage caused by inorganic biomaterials. The 
Comet assay is quick, uncomplicated, sensitive, accurate and cost-effective. What 
makes this test more interesting is that it can be applied to virtually any cell type 
and can be used alongside other standard assays, therefore, reducing the time and 
expenses associated with toxicity testing, while increasing the accuracy of information 
(Tables 3.2 and 3.3). 
3.2.6.2 Other Useful In Vitro Assessment Tests Related to Inorganic 
Biomaterials
The medical application of inorganic biomaterials is well established in the literature. 
Most if not all of these studies have conducted some sort of in vitro biocompatibility 
tests. However, apart from toxicity and biocompatibility, in vitro studies can be used 
to investigate the success of such inorganic biomaterials in achieving their designed 
purpose, for example, bone tissue engineering. 
HA, for example, has been extensively tested in vitro in order to investigate its 
interactions with living cells and tissues for the purpose of growing bone. In an ideal 
case, one would like a HA-based device or an implant seeded with stem cells, such 
as bone marrow-derived mesenchymal stem cells, to first interact with collagen, and 
later to observe the accumulation of proteins and cells on its surface followed by 
degradation of the material as the bone grows in its place. This process can be studied 
using in vitro assays such as quantitative DNA assays, alkaline phosphatase (ALP) 
assay, calcium assay and osteocalcin ELISA. 
Quantitative DNA assays are generally used to determine the seeding efficiency and 
cell growth on a test subject. These assays are relatively simple, time and cost-effective 
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as well as accurate. The ALP assay, on the other hand, is based on measuring a 
membrane-bound enzyme, as a marker for osteogenic differentiation on the scaffolds. 
The ALP assay is a rapid and quantitative test which allows accurate determination of 
whether or not HA can be used to promote bone growth for various purposes, such 
as dental and orthopaedic applications. The calcium assay and osteocalcin assay tend 
to assess bone growth by measuring the amount of calcium or osteocalcin protein 
deposited in the cell-scaffold constructs, respectively. Calcium is a major material in 
bone and teeth mineralisation and hence is a good marker to assess bone growth. 
All of the above assays are used to target a particular marker, for example, an enzyme 
or protein, to determine if bone growth will be of major use in clinical practice; 
however, it is not clear which assay has the better clinical application and the lack 
of or poor comparability between different assays makes it difficult to decide which 
of these tests should be definitively performed when investigating an inorganic 
biomaterial such as HA. 
On the subject of bone tissue engineering and bone repair, in addition to the above-
mentioned tests, another method, using simulated body fluids (SBF) is commonly 
practiced in vitro. This technique involves soaking bioceramics such as HA, 
β-tricalcium phosphate (β-TCP) and bioglass 45S5 in SBF to evaluate the ability of 
that particular bioceramic to form an apatite layer. SBF is a useful method to test the in 
vitro bioactivity of bioceramics and its reliability depends upon the type of bioceramics 
tested. For example, silicate ceramics have shown very good apatite-forming abilities 
in SBF while other bioceramics have shown no apparent sign of bioactivity when 
soaked in SBF for a short period of time. However, the bioactivity of the latter group 
has been demonstrated by in vivo studies. These findings suggest that although SBF is 
a good testing technique for some forms of bioceramics, it is however, not sufficient 
for other types such as phosphate-based or carbonate-based bioceramics and has 
to be used in conjunction with other methods. This phenomenon can be explained 
by the difference in the biochemistry of in vivo apatite and bone formation of these 
different types of bioceramics (Evaluation of the In Vitro Bioactivity of Bioceramics). 
In the case of resorbable inorganic biomaterials such as resorbable bioceramics, in 
vitro biological assessment is an essential step to monitor the rate of resorption of the 
material. In most studies these materials are placed in a simulated aqueous humour 
which mimics the inorganic component of the human aqueous humour. In such studies, 
the degradation rates are calculated based on the release of calcium or phosphate from 
the bioceramics, such as HA or TCP, using different assays such as high-performance 
liquid chromatography (HPLC) and gel permeation liquid chromatography to measure 
the rate of degradation of the implant while inside the host. In addition to these, 
more accurate quantification can be obtained using HPLC designed to separate the 
various components of a solution, and to identify and quantify each of the separated 
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components. In the case of inorganic biomaterials they can be used to identify and 
quantify components of the implant (e.g., calcium) which have been released into the 
liquid system of their host after going through the degradation process. 
In addition to investigating the biocompatibility, toxicity, organ formation (e.g., 
bone) and biodegradation, in vitro tests can be used to evaluate the material/device 
interaction with the cellular and protein components of blood. These tests, such as 
thrombus assessment, coagulation assessment and platelets and platelet function 
assessment, investigate the extent and site of thrombus formation, the presence of 
coagulation proteins (e.g., thrombin-antithrombin complex and fibropeptide A) and 
the number of platelets, respectively, when a material or device is placed inside the 
host. The interaction between the implant and blood has a significant effect on the 
biocompatibility of that implant. For instance, high levels of coagulation cascade 
activation observed during a coagulation assessment assay, may indicate unfavourable 
levels of device or material-related thrombin activity and fibre formation. (The most 
common tests used for in vitro assessment are summarised in Table 3.2 and Table 3.3). 
3.2.6.3 Summary
In vitro tests are the most frequently conducted because they are less complicated, 
cheaper and more reproducible compared with in vivo tests. In order to benefit from 
these advantages it is advisable to investigate different in vitro assays and choose 
the one that is most suitable for your particular application, and one that is in 
accordance with current rules and regulations set by the International Organization 
for Standardization (ISO) and the US Food & Drugs Administration. Once the assay 
has been chosen, decide on the cell type, number of cells, duration of exposure, test 
sample size, and the use of positive and negative controls to determine the viability 
of your test. Care should be taken when using information obtained from any of the 
mentioned assays as sometimes they can be misleading. This is especially true about 
the Ames assay, in which using fewer than four strains of Salmonella typhimurium 
can lead to false positive or false negative toxicity results. 
3.3 In Vivo Assessment
3.3.1 Introduction
The in vitro environment does not mimic the physiological conditions present inside 
the body and thus to assess the true effect of materials, in vivo assessment of tissue 
compatibility or biocompatibility is necessary. This is performed to ensure material 
safety for in-human applications. Depending upon the stage of biocompatibility 
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testing, for example, early stages of material analysis or following promising results 
from in vitro experiments, it will be crucial to choose the right type of in vivo test, 
one that would provide the most relevant and precise information for the purpose 
of that particular investigation. In vivo testing is an important part of research as 
small or larger animal models are used to investigate a particular material and its 
effect inside its living host; therefore, avoiding unnecessary or unsafe direct human 
testing. In vivo testing ensures that materials are risk-free both in the short term (few 
weeks) and long term (few months or longer). In vivo animal studies are fundamental 
to understanding the mechanism of biomaterial interactions with living tissue as a 
whole, allowing for any unanticipated outcome to be found and rectified prior to 
conducting any in-human clinical studies. 
3.3.2 Properties Assessed during In Vivo Tests
This section highlights tests which are considered for the general in vivo analysis 
of biomaterials based on the ISO standard recommendations. These include testing 
for cytotoxicity, sensitisation and irritation, based on ISO 10993-1. Cytotoxicity 
is, however, an in vitro test. A summary of these tests is listed in Table 3.4 and 
schematically shown in Figure 3.3. The choice of in vivo test will depend upon the 
properties of the material and its end use as a biomaterial. 
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Figure 3.3 Components of in vivo biocompatibility assessment
3.3.2.1 Sensitisation, Irritation and Intracutaneous Reactivity
These tests mainly look at the effect of materials/devices or their leachability on skin 
tissue in terms of sensitisation or allergic reactions. Sensitisation or allergic reactions 
due to leachable chemicals are commonly tested on skin; whereas tests for irritation 
use extracts of biomaterials and look at their effect on local tissue. Intracutaneous 
tests, as their name suggests, are used to check the reactivity of intradermal tissue by 
injecting extracts of materials or devices.
3.3.2.2 Systemic Toxicity
Systematic toxicity tests look at the effect of new materials or devices, focusing on 
substances which may have leached into the body. Various chemical and physical 
properties of the material are considered when designing this type of test. Systematic 
toxicity tests can be categorised into four subsections; acute, subacute, subchronic 
and chronic toxicity, based on the duration it takes from introducing the test material 
into the animal model and for the adverse effects to be observed (Figure 3.4). Acute 
toxicity is considered to be those adverse effects observed after 24 h of administration 
of single or multiple doses of leachable materials, while subacute toxicity, and 
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subchronic toxicity refer to adverse effects presented after 14−28 days and up to 90 
days, respectively. Furthermore, the extension of subchronic toxicity is termed as 
chronic toxicity which involves a period of over 90 days. 
Systemic
Toxicity
Acute Sub-actute Sub-chronic Chronic
< 24 hr 24 hr > 28 d 28 d < 90 d 90 d <
Figure 3.4 Division of systemic toxicity based on the duration of when the toxic 
response is observed in the host
3.3.2.3 Genotoxicity
Similar to the in vitro genotoxicity tests (Table 3.3), in vivo genotoxicity tests also 
look at changes in DNA which lead to the modification of cellular behaviour, such as 
proliferation and differentiation. In vivo micronucleus tests on rodents are the main 
type of testing techniques used to assess genotoxicity in living organisms. However, 
other tests such as the bone marrow cytogenetic test, chromosomal analysis, the 
rodent dominant lethal test and the mammalian germ cell cytogenetic assay can also 
be used. However, the choice of test will depend on the test material, its properties 
and procedural feasibility. 
3.3.2.4 Implantation
This test is used to assess the possible pathological effect of the implanted material on 
the structure and function of the surrounding living tissues. The tissue surrounding the 
implant is analysed at a microscopic level using histological techniques. Commonly, 
immunological staining of histological sections is used to determine the type of cell 
surrounding the implant, collagen deposition and arrangement, and so on. Other 
information which is assessed during an implantation test include distribution and the 
number of inflammatory cells as well as their distance from the implant, and thickness 
and vascularity of the fibrous capsule. The quality and quantity of tissue growth 
inside or around the porous materials, tissue apoptosis, necrosis, cell proliferation 
rate, thrombus formation and endothelisation are other aspects that can be assessed 
during an in vivo implantation study. The choice of animal used for this purpose is 
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generally dependent on various factors such as the site of implantation, duration, size 
and the information required. Short-term studies of up to 12 weeks can be carried out 
in small animals such as rats, mice or rabbits, while long-term studies are normally 
conducted in large animals such as pigs, sheep or young cows. 
3.3.2.5 Haemocompatibility
This test is used to study the effect of blood and its components on medical devices/
materials. In vivo haemocompatibility tests are mainly designed to simulate the 
geometry, contact and flow dynamics of the tissue of interest. These tests are very 
important in the design of vascular biomaterials, heart valves and other similar 
devices. However, in general, haemocompatibility also provides information on the 
biocompatibility of medical devices/biomaterials which require contact with blood 
and are susceptible to an immune response, for instance, orthopaedic or dental 
biomaterials made of inorganic biomaterials, e.g., metal and essential minerals, such 
as calcium-based composites. The use of haemocompatibility tests are common and 
widely accepted for devices where thrombosis, coagulation and platelet activation 
have an important role to play in determining the success of the test material.
3.3.2.6 Carcinogenicity 
Carcinogenicity tests are used to assess the tumourigenic effects of medical materials 
or their extracts. Tumourigenic effects caused by medical devices are not common, 
however, leachable materials can be considered as a likely cause of tumour formation. In 
addition, with the increased use of nano and microscale materials for biocompatibility 
coatings, their tumourigenic effect needs to be fully understood, using in vitro and 
in vivo assays, if the carcinogenicity of devices/materials are to be better evaluated.
3.3.2.7 Reproductive and Developmental Toxicity
These tests are designed to evaluate the effect of medical devices/materials or their 
extracts on the reproductive function, embryonic development, and prenatal and 
early postnatal development of living organisms. Tests and bioassays for this purpose 
are considered only when there is a possible negative impact on the reproductive 
potential of the host.
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3.3.2.8 Biodegradation
This test is important for medical devices/materials which are likely to produce 
degradation products in response to the surrounding environment. Intentionally 
degradable biomaterials, such as degradable polymeric scaffolds, can leach out 
impurities, catalysts or other additives to the surrounding tissue and distant organs, 
while similarly, metallic and polymeric wear particles from the mechanical wear and 
tear of orthopaedic implants could also find their way into the surrounding tissues 
and organs, affecting their functionality. In vivo biodegradation tests can be designed 
to evaluate the effects of anticipated degradation products separately, and identify 
those that might impose potentially risky or negative impacts on the host tissues and 
organs. Specific tissue responses can be studied using histological analysis.
3.3.3 Immune Responses
Immune response evaluation is not part of the standard in vivo tissue compatibility 
assessment. However, efforts have been made to standardise protocols to document 
the effects of the immune response which are triggered by biomaterials and devices. 
Such tests are particularly important where modifications of natural biomaterial, for 
example, modified protein-based scaffolds, are suspected to induce immune toxicity. 
It should be noted that there is currently no specific guideline for testing the host 
immune response to inorganic biomaterials in place.
3.4 Case Studies
Raw material characterisation, in vitro and in vivo testing are all crucial components 
of a comprehensive study with the aim of developing a biocompatible product with 
medical applications in humans. Planning a workflow for the in vitro and in vivo 
assessment of biocompatibility is shown in Figure 3.5. The present two case studies 
on inorganic biomaterials can be used to demonstrate what information can be gained 
using any of these three types of studies and how this information can be interpreted 
in a comprehensive study with a medical application potential. 
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In vitro and in vivo
Assessment of
Biocompatibility
Step 1 - Determine test
required
Categorise
device/drug/chemical
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literature for the
material under
investigation
Determine sample
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Determine most
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material application
Source the material
and evaluate the cost
and time line involved
Determine conditions
or instrumentation
required
Step 2 - prepare for chosen
test
Figure 3.5 Planning a workflow for the in vitro and in vivo assessment of 
biocompatibility
3.4.1 Case Study 1
Inorganic biomaterials have many medical applications, one of which is treating 
cancer. Currently, radiotherapy is one of the most routinely practiced treatments for 
cancer. Although radiotherapy has been established as an effective method for treating 
cancer, it has become apparent that it is not as suitable for deep-seated cancers, as 
only a small dose of radiation penetrates deep enough to destroy this group of cancers. 
Furthermore, concerns exist regarding the potential damage to healthy tissues caused 
by radiotherapy. Ceramic microspheres might be the solution to these problems. 
Previous studies have reported that 20–30 μm diameter 17Y2O3-19Al2O3-64SiO2 
(mol%) glass microspheres are useful for the in situ irradiation of cancer [15]. This is 
achieved by neutron bombarding the yttrium-89 (89Y) in this type of glass to create 
the μ-emitter 90Y (half-life = 64.1 h). By implanting such activated glass microspheres 
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into the target tumour tissue, a larger localised dose of β-radiation is delivered to the 
cancerous area (Figure 3.6). In living tissue, β-radiation has a short penetration range 
(approximately 2.5 mm); therefore, the radiation emitted to the surrounding healthy 
tissue is minimal [16]. These glass microspheres, which have already been used in 
Canada, the USA and European countries to treat liver cancer [17], are particularly 
interesting because they exhibit high chemical durability. This high durability is 
important for their application in cancer treatment as it enables radioactive 90Y 
to remain within the microspheres inside the host and therefore, not affecting the 
surrounding healthy tissue whilst radiating the cancerous tissue. 
Blood vessel
Catheter
Tumour
β−rayRadioactive glass
microsphere
(20−30 µm)
Figure 3.6 Schematic diagram of the local embolic radiotherapy of a tumour using 
yttrium-containing glass microspheres (20–30 nm in diameter). Reproduced with 
permission from Z.Z. Li and M.M. Kawashita, Journal of Artificial Organs, 2011, 
14, 3, 163. ©2011, Springer [16]
In an attempt to treat cancer safely and effectively, resorbable calcium-phosphate 
ceramic microspheres have also been incorporated with TNP-470, an antiangiogenic 
agent, developing a novel chemoembolisation approach to target human solid tumours 
[17]. In this study, the human uterine sarcoma cell line FU-MMT-3 was used as a 
target since this type of tumour is very aggressive and unreceptive to contemporary 
radiotherapy or chemotherapy treatments. Here, FU-MMT-3 xenografts I nude mice 
were injected with calcium phosphate ceramic microspheres carrying TNP-470. The 
treatment was carried out three times per week for 8 weeks and the results showed 
suppression of tumour growth compared with the control treatments. A significant 
decrease in the intratumoural vascularity was also observed following the treatment 
with microspheres carrying TNP-470. This is probably due to the remarkable 
embolisation of the ceramic microspheres in the tumour microvessels and feeding 
arteries. 
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The use of ceramic microspheres for treating cancer has shown positive results for 
the effective and safe treatment of locally advanced or recurrent solid tumours, both 
in vitro and in vivo, during the above studies. However, the short half-life of these 
microspheres, their rapid decay even prior to cancer treatment, and their limited 
capacity to carry a large dosage of antitumour agents are important issues that 
need to be addressed by conducting further comprehensive studies. Furthermore, 
other independent in vitro assessments of ceramic microspheres, using common 
biocompatibility, toxicity and bioactivity assays, have indicated that these types of 
inorganic biomaterials are considered biocompatible, nontoxic and safe for various 
medical applications [18, 20, 21]. For instance, in vitro tests using DNA analysis 
results revealed that the microspheres might be cell biocompatible for a minimum 
of seven days when tested at a concentration of <7.5 g/l of medium [21]. The release 
profile of TNP-470 from ceramic microspheres was also investigated in vitro, 
which showed that almost 75% of TNP-470 was released within the first 30 min 
of immersion, while the remaining 25% was released at a slower rate taking up to 
25 h [17]. Furthermore, inhibitory effects studied using in vitro assays, revealed that 
ceramic microspheres alone have no inhibitory effect on the proliferation of cancer 
cells, whereas those loaded with 500 or 1,000 μg/ml TNP-470 significantly inhibited 
the proliferation of FU-MMT-3 cells. 
3.4.2 Case Study 2
Hydrothermal methods of synthesising HA have been around for a few decades 
now. Liu and co-workers [21] used a simplified hydrothermal method to synthesise 
powders consisting of crystallised HA and used various characterisation techniques 
including TEM, XRD, SEM and a microVickers indentation method, to investigate 
the powder morphology, crystalline phase, microstructure and mechanical strength, 
respectively. These techniques revealed the powder to consist of crystallised HA in a 
needle shape, 130−170 nm in length and 15−25 nm in width, while no decomposition 
was observed using XRD. SEM and mechanical testing revealed a pore-free surface 
structure with a flexural strength, microVickers hardness and a fracture toughness 
of 120 MPa, 5.1 GPa and 1.2 MPa.m1/2, respectively. 
A very similar principle of synthesis was adopted by a more recent study conducted 
by Okuda and co-workers [22], who compared hydrothermally synthesised HA 
(HHA) with rod-shaped particles against stoichiometric HA (SHA) with globular-
shaped particles. They used various in vitro assays, to investigate the interactions 
of the bone cells on the surface of HHA and SHA, and in vivo histological studies, 
using rabbit models, to analyse the biological response of the host to HHA and 
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SHA. Using powder XRD with graphite-monochromatised CuKα radiation, they 
reported no phase other than HA for HHA and SHA, meaning that they were both 
pure and uniform. Furthermore, SEM and MIP were used to characterise the surface 
of HHA and SHA, as well as the pore volume and distribution of pore diameter, 
respectively. It was revealed that HHA was composed of micropores of 0.2 μm in 
size formed by tangled rod-shaped particles of about 20 μm in length, while SHA 
was composed of fused globular particles in the form of micropores of about 0.5 μm 
in size (Figure 3.6). 
Figure 3.7 Scanning electron micrographs of the microstructure of (a) HHA, and 
(b) SHA. Reproduced with permission from T. Okuda, K. Ioku, I. Yonezawa,  
H. Minagi, Y. Gonda, Gi. Kawachi, M. Kamitakahara, Y. Shibata, H. Murayama, 
H. Kurosawa, T. Ikeda, Biomaterials, 2008, 29, 2719. ©2008, Elsevier [22]
The in vivo studies, on the other hand, in which HHA and SHA were implanted into 
rabbit femurs, concluded that HHA had a significantly higher mineral apposition rate 
compared with SHA (Figure 3.7), suggesting that the microstructure of the inorganic 
biomaterials influenced the biological activity of osteoblast cells, even though they 
had exactly the same composition. Furthermore, the in vivo studies demonstrated that 
the bioactive response of the osteoblasts to HA nanoparticles is very much dependent 
on the particle size [22].
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4 weeks
HHA
SHA
12 weeks 24 weeks 72 weeks
a
e f g h
b c d
Figure 3.8 Soft X-ray photographs of the operated portion of the rabbit femur. (a) 
4 weeks, (b) 12 weeks, (c) 24 weeks and (d) 72 weeks after implantation of HHA; 
(e) 4 weeks, (f) 12 weeks, (g) 24 weeks, and (h) 72 weeks after implantation of 
SHA. Involvement of HHA in bone tissue was evident at 72 weeks (h). Reproduced 
with permission from T. Okuda, K. Ioku, I. Yonezawa, H. Minagi, Y. Gonda,  
G. Kawachi, M. Kamitakahara, Y. Shibata, H. Murayama, H. Kurosawa, T. Ikeda, 
Biomaterials, 2008, 29, 2719. ©2008, Elsevier [22] 
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